pET-28a-hPKM2 Citations (4)
Originally described in: Pyruvate kinase M2 is a phosphotyrosine-binding protein.Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC Nature. 2008 Mar 13;452(7184):181-6. doi: 10.1038/nature06667. PubMed Journal
Articles Citing pET-28a-hPKM2
Articles |
---|
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. Shankar Babu M, Mahanta S, Lakhter AJ, Hato T, Paul S, Naidu SR. PLoS One. 2018 Feb 2;13(2):e0191419. doi: 10.1371/journal.pone.0191419. eCollection 2018. PubMed |
CARM1 suppresses de novo serine synthesis by promoting PKM2 activity. Abeywardana T, Oh M, Jiang L, Yang Y, Kong M, Song J, Yang Y. J Biol Chem. 2018 Sep 28;293(39):15290-15303. doi: 10.1074/jbc.RA118.004512. Epub 2018 Aug 21. PubMed |
Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity. Verma K, Patel A. PLoS One. 2019 Feb 8;14(2):e0211515. doi: 10.1371/journal.pone.0211515. eCollection 2019. PubMed |
Purification and Characterization of Prolyl Hydroxylase 3/Pyruvate Kinase Isoform 2 Protein Complex. Kumar S, Patel AK. Mol Biotechnol. 2020 Feb;62(2):111-118. doi: 10.1007/s12033-019-00228-9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.